Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-09-15

FDA Approved: ZIRGAN — Original Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved Zirgan (ganciclovir ophthalmic gel) under its original application by Bausch & Lomb for the treatment of cytomegalovirus retinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZIRGAN (GANCICLOVIR)

Snippet

ORIG AP for ZIRGAN (GANCICLOVIR)